Cargando…

Early oseltamivir therapy improves the outcome in critically ill patients with influenza: a propensity analysis

Detalles Bibliográficos
Autores principales:	Hernu, Romain, Chroboczek, Tomasz, Madelaine, Thomas, Casalegno, Jean-Sebastien, Lina, Bruno, Cour, Martin, Argaud, Laurent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095308/ https://www.ncbi.nlm.nih.gov/pubmed/29026934 http://dx.doi.org/10.1007/s00134-017-4953-3

Ejemplares similares

Burden of critically ill patients with influenza in a French catchment population
por: Hernu, Romain, et al.
Publicado: (2021)

Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
por: Simon, Marie, et al.
Publicado: (2013)

Long-Term Outcome of Critically Ill Adult Patients with Acute Epiglottitis
por: Chroboczek, Tomasz, et al.
Publicado: (2015)

Management of Metformin-Associated Lactic Acidosis by Continuous Renal Replacement Therapy
por: Keller, Geoffray, et al.
Publicado: (2011)

Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
por: Moreno, Gerard, et al.
Publicado: (2021)

Predictors of haemodynamic instability during the changeover of norepinephrine infusion pumps
por: Cour, Martin, et al.
Publicado: (2016)

Risk factors for progression toward brain death after out-of-hospital cardiac arrest
por: Cour, Martin, et al.
Publicado: (2019)

Coronavirus disease 2019 as a particular sepsis: a 2-week follow-up of standard immunological parameters in critically ill patients
por: Monneret, Guillaume, et al.
Publicado: (2020)

Longitudinal assessment of IFN-I activity and immune profile in critically ill COVID-19 patients with acute respiratory distress syndrome
por: Venet, Fabienne, et al.
Publicado: (2021)

Short- and long-term outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis
por: Faucher, Etienne, et al.
Publicado: (2016)

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study
por: Aljuhani, Ohoud, et al.
Publicado: (2023)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Plasma Concentrations of Oseltamivir and Oseltamivir Carboxylate in Critically Ill Children on Extracorporeal Membrane Oxygenation Support
por: Wildschut, Enno D., et al.
Publicado: (2010)

Pharmacokinetics of oseltamivir carboxylate in critically ill patients: each patient is unique
por: Kromdijk, W., et al.
Publicado: (2013)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2
por: Domenech de Cellès, Matthieu, et al.
Publicado: (2021)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis
por: Shen, Kunling, et al.
Publicado: (2016)

Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study
por: Dananché, Cédric, et al.
Publicado: (2015)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
por: Meijer, Wouter J., et al.
Publicado: (2015)

Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the Influenza Resistance Information Study
por: Lina, Bruno, et al.
Publicado: (2018)

Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015–2016
por: Hamdan, Lubna, et al.
Publicado: (2021)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
por: Chan, Renee W. Y., et al.
Publicado: (2022)

Decreased Hospital Length of Stay With Early Administration of Oseltamivir in Patients Hospitalized With Influenza
por: Dou, Lin, et al.
Publicado: (2020)

Synergistic Effects of Influenza and Staphylococcus aureus Toxins on Inflammation Activation and Cytotoxicity in Human Monocytic Cell Lines
por: Jeannoel, Marion, et al.
Publicado: (2018)

Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia
por: Kositpantawong, Narongdet, et al.
Publicado: (2021)

Adherence to Oseltamivir Guidelines during Influenza Pandemic, the Netherlands
por: Fietjé, Esther H., et al.
Publicado: (2012)

Oseltamivir resistance in swine influenza: a brief discussion
por: Wiwanitkit, Viroj
Publicado: (2009)

Oseltamivir use amongst hospitalized patients infected with influenza
por: Herman, Michael, et al.
Publicado: (2014)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

Oseltamivir treatment of influenza A and B infections in infants
por: Mattila, Janna‐Maija, et al.
Publicado: (2021)

Evaluation of the Clinical Effectiveness of Oseltamivir for Influenza Treatment in Children
por: Qin, Jianru, et al.
Publicado: (2022)

Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Cyclosporine A: a valid candidate to treat COVID-19 patients with acute respiratory failure?
por: Cour, Martin, et al.
Publicado: (2020)

Airway Closure and Expiratory Flow Limitation in Acute Respiratory Distress Syndrome
por: Guérin, Claude, et al.
Publicado: (2022)

Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients
por: Bouadma, Lila, et al.
Publicado: (2019)

Delivery of high flow oxygen through nasal vs. tracheal cannulas: A bench study
por: Cour, Martin, et al.
Publicado: (2023)

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
por: Duval, Xavier, et al.
Publicado: (2010)

Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model
por: Seldeslachts, Laura, et al.
Publicado: (2021)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
por: Meijer, Adam, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_dtjefdo4velarb3ml075ddgg0o